Immune Pharmaceuticals Inc (fka IMNPQ)

[nit2winit26]

ratify the selection of BDO USA, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016;

2. approve an increase to the amount of shares authorized under the Company’s 2015 Equity Incentive Plan from 5,000,000 to 15,000,000;

3. re-elect each of Mr. Daniel G. Teper and Mr. John Neczesny, nominees for Class III directors, as members of our Board of Directors; and

4. authorize an amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a specific ratio, within a range of 1-for- 2 and 1-for-25, to be determined by our Board of Directors in its sole discretion and effected, if at all, on or before December 15, 2017. <______________________Why i wont buy. Because it says on or before December 15,2017 so once they get the increase boom reverse split then dilution. Careful here guys.